These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1287401)
1. Reversal of drug resistance in Mycobacterium leprae by ampicillin/sulbactam. Prabhakaran K; Harris EB; Randhawa B; Hastings RC Microbios; 1992; 72(291):137-42. PubMed ID: 1287401 [TBL] [Abstract][Full Text] [Related]
2. Bactericidal action of oral ampicillin/sulbactam against Mycobacterium leprae. Randhawa B; Harris EB; Prabhakaran K J Antimicrob Chemother; 1999 Aug; 44(2):279-81. PubMed ID: 10473236 [TBL] [Abstract][Full Text] [Related]
3. Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents. Prabhakaran K; Harris EB; Randhawa B; Adams LB; Williams DL; Hastings RC Microbios; 1993; 76(309):251-61. PubMed ID: 8302203 [TBL] [Abstract][Full Text] [Related]
4. Bactericidal action of ampicillin/sulbactam against intracellular mycobacteria. Prabhakaran K; Harris EB; Randhawa B Int J Antimicrob Agents; 1999 Oct; 13(2):133-5. PubMed ID: 10595573 [TBL] [Abstract][Full Text] [Related]
5. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin. Walker LL; Van Landingham RM; Shinnick TM Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182 [TBL] [Abstract][Full Text] [Related]
6. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad. Hastings RC; Richard V; Christy SA; Morales MJ Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727 [TBL] [Abstract][Full Text] [Related]
7. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria]. González C; García A; Urrea R; del Solar E; Bello H; Zemelman R Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275 [TBL] [Abstract][Full Text] [Related]
8. Activity of beta-lactamase inhibitor sulbactam plus ampicillin against animal isolates of Pasteurella, Haemophilus, and Staphylococcus. Girard AE; Schelkly WU; Murphy KT; Sawyer PS Am J Vet Res; 1987 Dec; 48(12):1678-83. PubMed ID: 3501686 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae. Dhople AM Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam. Sader HS; Tosin I; Sejas L; Miranda E Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842 [TBL] [Abstract][Full Text] [Related]
11. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat. Fieldsteel AH; Levy L Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811 [TBL] [Abstract][Full Text] [Related]
12. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone. Gelber RH; Humphres RC; Fieldsteel AH Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770 [TBL] [Abstract][Full Text] [Related]
13. Are all nonsolid Mycobacterium leprae dead? Does a negative finding in the mouse foot pad indicate that there is actually no growth of M. leprae in the animals? Chang YT Int J Lepr Other Mycobact Dis; 1977; 45(3):235-40. PubMed ID: 336555 [TBL] [Abstract][Full Text] [Related]
14. Mouse foot pad growth of M. leprae in relation to bacteriological index. Bhatia VN; Balakrishnan S; Venkataramaniah HN; Harikrishnan S Lepr India; 1983 Apr; 55(2):247-51. PubMed ID: 6355651 [TBL] [Abstract][Full Text] [Related]
15. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains. Paniagua GL; Monroy E; García O; Vaca S Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy. Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796 [TBL] [Abstract][Full Text] [Related]
17. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244. Thomson JM; Distler AM; Bonomo RA Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099 [TBL] [Abstract][Full Text] [Related]
18. Postantibiotic effect of ampicillin/sulbactam against mycobacteria. Prabhakaran K; Harris EB; Randhawa B Microbios; 1999; 99(393):113-22. PubMed ID: 10510868 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae. Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663 [TBL] [Abstract][Full Text] [Related]
20. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds. Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]